New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxide-induced silicosis
Authors:
- Fang YangFYFang Yang
- Jingbo YanJYJingbo Yan
- Qian LiQLQian Li
- Zhongqiu WeiZWZhongqiu Wei
- Haili FengHFHaili Feng
- Ruimin WangRWRuimin Wang
- Lijuan ZhangLZLijuan Zhang
- Xuepeng ZhangXZXuepeng Zhang
- 1 August 2010
- journal article
- Published by Elsevier in Life Sciences
- Vol. 87 (7-8) , 232-239
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Pretreatment with Darbepoetin Attenuates Renal Injury in a Rat Model of Cisplatin-Induced NephrotoxicityThe Korean Journal of Internal Medicine, 2009
- Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulationJournal of Molecular Endocrinology, 2007
- Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal KinasesMicrobiology and Molecular Biology Reviews, 2006
- Basic pathogenetic mechanisms in silicosis: current understandingCurrent Opinion in Pulmonary Medicine, 2005
- Antifibrotic effect of interferon gamma in silicosis model of ratToxicology Letters, 2005
- Reduction of Cardiac Fibrosis Decreases Systolic Performance Without Affecting Diastolic Function in Hypertensive RatsHypertension, 2004
- Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis modelJournal of Leukocyte Biology, 1998
- High Plasma Level ofN-Acetyl-Seryl-Aspartyl-Lysyl-ProlineHypertension, 1997
- Conformation-dependent phosphorylation of p53Proceedings of the National Academy of Sciences, 1997
- Transforming Growth Factor β in Tissue FibrosisNew England Journal of Medicine, 1994